Chris Hughes

If the pharma giants shifts its primary listing to New York, the focus should be developing a successor.

UK investment trusts saw off activist Boaz Weinstein earlier this year, but they have been no match for the campaign that followed.

European dealmakers need to up their ambition.

It’s hard for active managers to beat passive funds in an equity bull market. But that doesn’t mean the current gyrations offer easy pickings.

Conglomerate corporations are being urged to do the splits. The case for simplification is so often obvious. Better for boards to bite the bullet than wait to be pushed.

It’s about time an investor like Boaz Weinstein tried to shake up this underperforming market niche.

Omnicom’s deal for Interpublic faces massive risks – from assuaging regulators to retaining clients and staff. But threats from AI mean doing nothing is riskier.

Boss Larry Fink is at it again, splashing out on an alternative asset manager. It’s risky, but he can afford it.

The planemaker may be a protected company, but investors colluded in its poor strategic, financial and operational management.

Senior creditors are extending painfully expensive new debt to the troubled utility. Junior creditors are disadvantaged too. Is there really no alternative?